Efficacy of mirtazapine in preventing delayed nausea and vomiting induced by highly emetogenic chemotherapy: An open-label, randomized, multicenter phase III trial.

被引：2
|
作者：
Cao, Jun
Wang, Biyun
Wang, Zhonghua
Zhang, Jian
Wang, Leiping
Cao, Enying
Zhao, Yannan
Feng, Zhe
Ouyang, Quchang
Wang, Shusen
Hu, Xichun
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Hu Nan Tumor Hosp, Changsha, Hunan, Peoples R China
[3] Canc Hosp Zhongshan Med, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.1078
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1078
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Mirtazapine, a dopamine receptor inhibitor, as a secondary prophylactic for delayed nausea and vomiting following highly emetogenic chemotherapy: an open label, randomized, multicenter phase III trial
    Cao, Jun
    Ouyang, Quchang
    Wang, Shusen
    Ragaz, Joseph
    Wang, Xiaojia
    Teng, Yuee
    Wang, Biyun
    Wang, Zhonghua
    Zhang, Jian
    Wang, Leiping
    Wu, Jiong
    Shao, Zhimin
    Hu, Xichun
    [J]. INVESTIGATIONAL NEW DRUGS, 2020, 38 (02) : 507 - 514
  • [2] Mirtazapine, a dopamine receptor inhibitor, as a secondary prophylactic for delayed nausea and vomiting following highly emetogenic chemotherapy: an open label, randomized, multicenter phase III trial
    Jun Cao
    Quchang Ouyang
    Shusen Wang
    Joseph Ragaz
    Xiaojia Wang
    Yuee Teng
    Biyun Wang
    Zhonghua Wang
    Jian Zhang
    Leiping Wang
    Jiong Wu
    Zhimin Shao
    Xichun Hu
    [J]. Investigational New Drugs, 2020, 38 : 507 - 514
  • [3] A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy
    Aogi, Kenjiro
    Sakai, Hiroshi
    Yoshizawa, Hirohisa
    Masuda, Norikazu
    Katakami, Nobuyuki
    Yanagita, Yasuhiro
    Inoue, Kenichi
    Kuranami, Masaru
    Mizutani, Mitsuhiro
    Masuda, Noriyuki
    [J]. SUPPORTIVE CARE IN CANCER, 2012, 20 (07) : 1507 - 1514
  • [4] A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy
    Kenjiro Aogi
    Hiroshi Sakai
    Hirohisa Yoshizawa
    Norikazu Masuda
    Nobuyuki Katakami
    Yasuhiro Yanagita
    Kenichi Inoue
    Masaru Kuranami
    Mitsuhiro Mizutani
    Noriyuki Masuda
    [J]. Supportive Care in Cancer, 2012, 20 : 1507 - 1514
  • [5] Efficacy of Thalidomide in Preventing Delayed Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase III Trial (CLOG1302 study)
    Zhang, Lingyun
    Qu, Xiujuan
    Teng, Yuee
    Shi, Jing
    Yu, Ping
    Sun, Tao
    Wang, Jingyan
    Zhu, Zhitu
    Zhang, Xiuna
    Zhao, Mingfang
    Liu, Jing
    Jin, Bo
    Luo, Ying
    Teng, Zan
    Dong, Yuyang
    Wen, Fugang
    An, Yuzhi
    Yuan, Caijun
    Chen, Tiejun
    Zhou, Lizhong
    Chen, Ying
    Zhang, Jian
    Wang, Zhenghua
    Qu, Jinglei
    Jin, Feng
    Zhang, Jingdong
    Jin, Xiuhua
    Xie, Xiaodong
    Wang, Jun
    Man, Li
    Fu, Lingyu
    Liu, Yunpeng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (31) : 3558 - +
  • [6] Efficacy of the granisetron transdermal system for the control of nausea and vomiting induced by highly emetogenic chemotherapy: a multicenter, randomized, controlled trial
    Sun, Der Sheng
    Ko, Yoon Ho
    Jin, Jong Youl
    Woo, In Sook
    Park, Suk Young
    Eom, Yun Ae
    Kang, Jin Hyoung
    Kim, Hoon Kyo
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (03): : 406 - +
  • [7] A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy
    Aapro, M. S.
    Grunberg, S. M.
    Manikhas, G. M.
    Olivares, G.
    Suarez, T.
    Tjulandin, S. A.
    Bertoli, L. F.
    Yunus, F.
    Morrica, B.
    Lordick, F.
    Macciocchi, A.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (09) : 1441 - 1449
  • [8] Aprepitant plus palonosetron versus dexamethasone plus palonosetron in preventing chemotherapy- induced nausea and vomiting in patients with moderate-emetogenic chemotherapy: A randomized, open-label, phase 3 trial
    Cheng, Yi
    Wu, Zehua
    Shi, Lishuo
    Shen, Cailu
    Zhang, Jianwei
    Hu, Huabin
    Li, Weiwei
    Cai, Yue
    Xie, Xiaoyu
    Ling, Jiayu
    Zheng, Qin
    Deng, Yanhong
    [J]. ECLINICALMEDICINE, 2022, 49
  • [9] Olanzapine for Preventing Nausea and Vomiting Induced by Moderately and Highly Emetogenic Chemotherapy
    Wang, Shi-Yong
    Yang, Zhen-Jun
    Zhang, Lu
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (22) : 9587 - 9592
  • [10] Effect of Ginger on Acute and Delayed Chemotherapy-Induced Nausea and Vomiting: A Pilot, Randomized, Open-Label Clinical Trial
    Panahi, Yunes
    Saadat, Alireza
    Sahebkar, Amirhossein
    Hashemian, Farshad
    Taghikhani, Mojgan
    Abolhasani, Ehsan
    [J]. INTEGRATIVE CANCER THERAPIES, 2012, 11 (03) : 204 - 211
12345